James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 3,966 shares at $42.42 ($169K) on 2025-03-11, disclosed to the SEC on 2025-03-12.
Seasonal sale ($169k) by General Counsel and Secretary — this insider has traded CRSP in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.42 | 2,850 | $121K | 71.4% |
| 2 | $43.32 | 1,116 | $48K | 28.6% |
| Total | $42.67 avg | 3,966 | $169K | 100% |
| Filing → |
| CRSP | SELL | 2026-03-17 | $166K | — | Filing → |
| CRSP | SELL | 2026-03-12 | $148K | — | Filing → |
| CRSP | SELL | 2026-02-20 | $111K | — | Filing → |